STSS: Sharps Technology Company Total Sales

The rise of global healthcare worker safety standards is driving the scaling demand for smart syringes. Sales figures for Sharps Technology, Inc. (STSS) reflect this trend, with the current metric standing at 0.01. While the development of needle safety systems limits pricing power in the mass market, a strong engineering team and a flexible corporate culture ensure high-quality business development.

Sharps Tech (STSS) - Company Sales from 04/28/2023 to 05/28/2026

Comprehensive metric breakdowns and analytics for Sharps Technology Inc (STSS)

- market value and analyst target forecast:

Market Chart Sharps Tech|STSS - Consensus Target

- market capitalization information:

Market Value Sharps Technology|STSS - Total Company Value

- book capitalization indicators:

Accounting Value of a Share Sharps Technology, Inc.|STSS - Company Net Assets|Market Capitalization to Book Value Ratio sharpstechnology.com|STSS - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and valuation multiples indicators:

STSS - Company Net Income|Company Profit Forecast Sharps Technology, Inc.|STSS - P/E Multiple|Future Price to Earnings Multiple Sharps Tech|STSS - PEG Multiple|EV/EBITDA Multiple Sharps Technology|STSS - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Sharps Technology, Inc.|STSS - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months sharpstechnology.com|STSS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Sharps Technology, Inc.

- issuer revenue and sales details:

STSS - Company Sales|Company Future Revenue Sharps Tech|STSS - Market Cap to Revenue|Price to Expected Revenue Ratio Sharps Technology

Comprehensive company analysis:sharpstechnology.com STSS

The fundamental risks of the asset are determined through an analysis of actual cash flows. Investments in the engineering potential of Sharps Technology, Inc. (STSS) to create safe syringes require validation via commercial efficiency. The company's total trade revenue captures actual customer receipts, eliminating informational noise. This indicator measures objective demand for products on a daily basis. Growth in this metric confirms the capitalization of innovations and the absence of capital freeze risks.

Competing companies